{"cluster": 0, "subcluster": 2, "abstract_summ": "CONCLUSION: The data imply that a) COVID-19 can lead to hyposmia in a relevant number of patients, the incidence was approximately 30% in this cohort; b) in most cases, the olfactory disturbance was not associated with nasal obstruction, thus indicating a possible neurogenic origin; and c) the olfactory disorder largely resolved within 1\u20133 weeks after the onset of COVID-19 symptoms.CONCLUSION: Olfactory and gustatory dysfunctions represent common clinical findings in COVID\u201019 patients.METHODS: Loss of sense of smell and/or taste was reported by 26 of 63 COVID-19 patients (41%), whereas only 31% of the patients experiencing hyposmia had simultaneous symptoms of rhinitis.Abstract Objectives To detailly described the neurosensory dysfunction, including hyposmia, hypogeusia and tinnitus, in patients with COVID-19.Objective: To investigate clinical and radiological features of olfactory clefts of patients with mild coronavirus disease 2019 (COVID-19).", "title_summ": "Isolated olfactory cleft involvement in SARS-CoV-2 infection: prevalence and clinical correlatesTempor\u00e4re Hyposmie bei COVID-19-PatientenObjective evaluation of anosmia and ageusia in COVID\u201019 patients: Single\u2010center experience on 72 casesOlfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case ReportNeurosensory dysfunction: a diagnostic marker of early COVID-19Clinical and Radiological Evaluations of COVID-19 Patients with Anosmia: Preliminary Report.", "title_abstract_phrases": "CONCLUSION: The data imply that a) COVID-19 can lead to hyposmia in a relevant number of patients, the incidence was approximately 30% in this cohort; b) in most cases, the olfactory disturbance was not associated with nasal obstruction, thus indicating a possible neurogenic origin; and c) the olfactory disorder largely resolved within 1\u20133 weeks after the onset of COVID-19 symptoms.CONCLUSION: Olfactory and gustatory dysfunctions represent common clinical findings in COVID\u201019 patients.Clinical and Radiological Evaluations of COVID-19 Patients with Anosmia: Preliminary Report.Methods: Sixteen COVID-19 patients were recruited.Neurosensory dysfunction: a diagnostic marker of early COVID-19Abstract Objectives To detailly described the neurosensory dysfunction, including hyposmia, hypogeusia and tinnitus, in patients with COVID-19."}